An Activatable and Covalent Tumor-Associated Antigen Capturer Enabling Systemic Injection In Vivo for Promoted Antitumor Immunity
Journal of the American Chemical Society · 2025
DOI: 10.1021/jacs.5c09791 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2025. Verfasst von Zhiyuan Gao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Frontiers Science Center for New Organic Matter, State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences and Academy for Advance…. Hauptthemen laut MEDLINE: Antigens, Neoplasm, Photosensitizing Agents, Antineoplastic Agents. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Nankai University, China Postdoctoral Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Antigen-capturing nanomaterials hold great promise for cancer immunotherapy; however, the need for tumor localized administration and limited antigen-binding affinity remains the "Achilles heel" of this strategy. Herein, we present a tumor microenvironment (TME)-activatable nanoplatform, TDR848@FPB, designed for systemic administration and enhanced covalent capture of tumor-associated antigens (TAAs), enabling effective immunotherapy with minimal off-target effects and independent of localized tumor administration. This platform encapsulates a photosensitizer-conjugated, light-activated toll-like receptor (TLR) agonist, which induces immunogenic cell death and triggers a pro-inflammatory TME conducive to antigen capture upon light irradiation. TDR848@FPB covalently binds TAA-generated postphotodynamic therapy and promotes their efficient delivery to enhance dendritic cell maturation, T cell activation, and immunogenetic reprogramming of the TME. Following intravenous injection and light irradiation, TDR848@FPB demonstrates superior 1O2 generation capability and TAA capture efficiency, leading to significant tumor growth inhibition. Moreover, the captured TAAs and TLR agonists synergistically activate adaptive antitumor immunity, as evidenced by their potentiated T cell responses. These findings highlight the critical role of TME-activatable covalent antigen capture in enabling systemic delivery of antigen-capturing nanomaterials and validate TDR848@FPB as a versatile platform for precise cancer immunotherapy with a high therapeutic outcome and low off-target effects, independent of tumor localized administration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Frontiers Science Center for New Organic Matter, State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences and Academy for Advanced Interdisciplinary Studies, Nankai University, Tianjin 300071, PR Chi…
- Nankai International Advanced Research Institute (Shenzhen Futian), Nankai University, Shenzhen 518045, PR China.
- School of Medicine, Nankai University, Tianjin 300071, PR China.
ORCID-Profile: Dan Ding
Förderung
- Nankai University
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
- Shenzhen Science and Technology Innovation Program
Zitieren
APA
Gao, Z., Miao, Z., Jia, S., Zhang, D., Zhang, H., Tian, J., Zhao, J., Xin, J., & Ding, D. (2025). An Activatable and Covalent Tumor-Associated Antigen Capturer Enabling Systemic Injection In Vivo for Promoted Antitumor Immunity. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.5c09791
Vancouver
Gao Z, Miao Z, Jia S, Zhang D, Zhang H, Tian J, et al. An Activatable and Covalent Tumor-Associated Antigen Capturer Enabling Systemic Injection In Vivo for Promoted Antitumor Immunity. Journal of the American Chemical Society. 2025. doi:10.1021/jacs.5c09791
BibTeX
@article{Gao2025,
author = {Gao, Zhiyuan and Miao, Zhizhao and Jia, Shaorui and Zhang, Dongping and Zhang, Hongkai and Tian, Jianwu and Zhao, Jiliang and Xin, Jingrui and Ding, Dan},
title = {An Activatable and Covalent Tumor-Associated Antigen Capturer Enabling Systemic Injection In Vivo for Promoted Antitumor Immunity},
journal = {Journal of the American Chemical Society},
year = {2025},
doi = {10.1021/jacs.5c09791}
}
EUVIMED